{
    "2020-02-05": [
        [
            {
                "time": "2023-02-15",
                "original_text": "Novo Nordisk (NVO) Q4 Earnings Match Estimates, Revenues Beat",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Q4 Earnings",
                        "Match Estimates",
                        "Revenues Beat"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-16",
                "original_text": "Stocks - GM Rises in Pre-market; Merck Falls on Spin-Off News",
                "features": {
                    "keywords": [
                        "GM",
                        "Rises",
                        "Pre-market",
                        "Merck",
                        "Falls",
                        "Spin-Off News"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "automotive",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-02-17",
                "original_text": "Glaxo says adjusted EPS slips as it prepares to split into two companies",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "adjusted EPS",
                        "slips",
                        "split",
                        "two companies"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}